Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765236015 | Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3765237012 | Valganciclovir (as valganciclovir hydrochloride) 50 mg/mL oral solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4528171000052110 | valganciklovir (som valganciklovirhydroklorid) 50 milligram/milliliter, oral lösning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | har täljarvärde för koncentrationsstyrka | 50 | false | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Has precise active ingredient | Valganciclovir hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Is a | Product containing only valganciclovir in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Has basis of strength substance (attribute) | Valganciclovir | true | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Has manufactured dose form | Oral solution | true | Inferred relationship | Some | ||
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) | Plays role | Antiviral therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR